Manresa, Spain

Anna Orriols

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 2 EPO patents. Top assignees: Ferrer Internacional, S.a., Fundacion Centrol Nacional De Investigaciones Cardiovasculares Carlos III. Active years: 2014.


% Patents Active = 100.0


 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Anna Orriols

Introduction

Anna Orriols is a notable inventor based in Manresa, Spain. She has made significant strides in the field of cardiovascular health through her innovative inventions. Her work focuses on developing solutions that can help prevent cardiovascular diseases, particularly in high-risk populations.

Latest Patents

Anna Orriols holds a patent for a capsule designed for the prevention of cardiovascular diseases. This invention comprises coated tablets of acetylsalicylic acid, coated tablets of simvastatin or pravastatin, and coated tablets of lisinopril, ramipril, or perindopril. The capsules are specifically formulated to aid in the prevention of cardiovascular diseases among individuals at high risk.

Career Highlights

Throughout her career, Anna has worked with esteemed organizations such as Fundación Centro Nacional De Investigaciones Cardiovasculares Carlos III and Ferrer Internacional, S.A. Her contributions to these institutions have been instrumental in advancing research and development in cardiovascular health.

Collaborations

Anna has collaborated with notable professionals in her field, including Pablo Martin and Manel Raga. These partnerships have enriched her work and expanded the impact of her inventions.

Conclusion

Anna Orriols is a pioneering inventor whose work in cardiovascular health is making a difference in the lives of many. Her innovative capsule for disease prevention exemplifies her commitment to improving health outcomes for high-risk populations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…